Pharmacokinetics and pharmacodynamics of canagliflozin in pediatric patients with type 2 diabetes
Pediatric Diabetes, EarlyView. (Source: Pediatric Diabetes)
Source: Pediatric Diabetes - December 22, 2017 Category: Endocrinology Source Type: research
---
Pediatric Diabetes, Ahead of Print. (Source: Pediatric Diabetes)
Source: Pediatric Diabetes - December 22, 2017 Category: Endocrinology Source Type: research
Pharmacokinetics and pharmacodynamics of canagliflozin in pediatric patients with type 2 diabetes
ConclusionsIn pediatric T2D patients, canagliflozin 100 and 300 mg had PK and PD characteristics similar to those in adults with T2D, which is likely due to the relative maturity and increased body weight of youth affected with this disorder. (Source: Pediatric Diabetes)
Source: Pediatric Diabetes - December 22, 2017 Category: Endocrinology Authors: William V Tamborlane, David Polidori, Domenick Argenti, Nicholas A Di Prospero Tags: ORIGINAL ARTICLE Source Type: research
Relationships among cardiorespiratory fitness, muscular fitness, and cardiometabolic risk factors in Japanese adolescents: Niigata screening for and preventing the development of non ‐communicable disease study‐Agano (NICE EVIDENCE Study‐Agano) 2
Pediatric Diabetes, EarlyView. (Source: Pediatric Diabetes)
Source: Pediatric Diabetes - December 19, 2017 Category: Endocrinology Source Type: research
